QA: Orgenesis Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2020_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 25,979,000
1 IntangibleAssetsNetIncludingGoodwill 29,147,000
2 PropertyPlantAndEquipmentNet 24,454,000
3 remainder_Assets 12,915,000
4 LiabilitiesCurrent 31,579,000
5 LiabilitiesNoncurrent 23,883,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 39,354,357
8 SellingGeneralAndAdministrativeExpense 70,486,684
9 ResearchAndDevelopmentExpense 42,391,568
10 remainder_Expenses 2,701,098
11 remainder_Revenues 92,915,940
12 remainder_NetIncome -368,427
13 remainder_ComprehensiveNetIncome 832,939
  yvar yval
0 Assets 92,495,000
1 Liabilities 55,462,000
2 Expenses 154,933,707
3 Revenues 92,915,940
4 StockholdersEquity 37,033,000
5 NetIncome -62,386,194
6 ComprehensiveNetIncome -61,969,724
7 BaseVar 198,504,006
8 EconomicCapitalRatiobeforeLimitedLiability 0.254
9 EconomicCapitalRatio 1.66

Edgar->Model Mapping

Feature Distribution

Change over Time